Abbott Laboratories

Abbott's Ellipse Recall Is the 33rd U.S. Medical Device Recall This Year
Abbott's Ellipse Recall Is the 33rd U.S. Medical Device Recall This Year
Medical Devices and Diagnostics Industry
Abbott Laboratories
product recalls
Ellipse Cardioverter Defibrillators
devices
Flag link:
Medtech's Biggest Deals in 2019 ... So Far
Medtech's Biggest Deals in 2019 ... So Far
Medical Devices and Diagnostics Industry
devices
M&A
Hill-Rom
Voalte
Abbott Laboratories
Cephea Valve Technologies
ZOLL Medical
TherOx
Stryker
Arrinex
Medtronic
Epix Therapeutics
Guardant Health
Bellwether Bio
Titan Spine
Bosotn Scientific
Vertiflex
Edward Lifesciences
CAS Medical Systems
Fresenius
NxStage
JNJ
Auris Health
Flag link:
Where Will Abbott Laboratories Be in 10 Years?
Where Will Abbott Laboratories Be in 10 Years?
Motley Fool
Abbott Laboratories
devices
Flag link:
Abiomed gains after Abbott tables HeartMate PHP program
Abiomed gains after Abbott tables HeartMate PHP program
Mass Device
Abiomed
Abbott Laboratories
HeartMate PHP program
Europe
devices
Flag link:
Abbott Laboratories’ 4Q15 Revenues Expected to Fall
Abbott Laboratories’ 4Q15 Revenues Expected to Fall
Yahoo/Market Realist
Abbott Laboratories
earnings
Flag link:
Abbott, GE Healthcare ink afib deal
Abbott, GE Healthcare ink afib deal
Mass Device
Abbott Laboratories
GE Healthcare
devices
atrial fibrillation
Flag link:
AstraZeneca digs into precision medicine with lung, heart deals
AstraZeneca digs into precision medicine with lung, heart deals
Yahoo/Reuters
AstraZeneca
precision medicine
Montreal Heart Institute
Abbott Laboratories
Flag link:
Teva, Actavis, Other Giants Set to Battle for Generics Space
Teva, Actavis, Other Giants Set to Battle for Generics Space
TheStreet.com
generics
Teva Pharmaceutical
Actavis
Abbott Laboratories
Flag link:
Abbott, AbbVie win dismissal of claims over Humira, AndroGel
Abbott, AbbVie win dismissal of claims over Humira, AndroGel
Yahoo/Reuters
Abbott Laboratories
AbbVie
Humira
Androgel
Flag link:
Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf
Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf
The Street
JNJ
Abbott Laboratories
Flag link:
Mylan near multibillion-dollar deal for Abbott drug assets - sources
Mylan near multibillion-dollar deal for Abbott drug assets - sources
Global Post
Mylan
Abbott Laboratories
Flag link:
Abbott Laboratories: Recent Emerging Market Acquisitions Boost Growth Profile
Abbott Laboratories: Recent Emerging Market Acquisitions Boost Growth Profile
Seeking Alpha
Abbott Laboratories
emerging markets
M&A
AbbVie
Veropharm
Flag link:
Abbott Labs Testosterone Suits Consolidated in Chicago
Abbott Labs Testosterone Suits Consolidated in Chicago
Bloomberg
Abbott Laboratories
Flag link:
Abbott's Promising Data on RADICAL Platform
Abbott's Promising Data on RADICAL Platform
Yahoo/Zacks.com
Abbott Laboratories
IRIDICA
Flag link:
Abbott taps Morgan Stanley to sell mature products - sources
Abbott taps Morgan Stanley to sell mature products - sources
Reuters
Abbott Laboratories
M&A
Flag link:
Big Pharma Diversification: A Winning Model or Recipe for Disaster?
Big Pharma Diversification: A Winning Model or Recipe for Disaster?
Motley Fool
Big Pharma
diversification
Merck
Eli Lilly
AbbVie
Abbott Laboratories
Pfizer
Flag link:
Abbott sued on claims of Androgel danger, Bloomberg says
Abbott sued on claims of Androgel danger, Bloomberg says
Yahoo/Fly on the Wall
Androgel
Abbott Laboratories
AbbVie
Flag link:
Abbott revenue misses, hurt by dollar, weak formula sales
Abbott revenue misses, hurt by dollar, weak formula sales
Yahoo/Reuters
Abbott Laboratories
earnings
Flag link:
Novavax:A Biotech Story Set To Double In 2014
Novavax:A Biotech Story Set To Double In 2014
Seeking Alpha
Novavax
Abbott Laboratories
Novartis
Baxter International
Virus-like Particles
recombinant protein micelles
Flag link:
Will Abbott Perform Better In 2014?
Will Abbott Perform Better In 2014?
Seeking Alpha
Abbott Laboratories
Flag link:

Pages